Does the SANO trial really move us toward organ preservation for esophageal cancer?

Sheraz R. Markar; Mark van Berge Henegouwen; Christiane Bruns; Lorenzo Ferri; Richard van Hillegersberg; Wayne Hofstetter; Magnus Nilsson

doi:10.1093/dote/doaf049

Does the SANO trial really move us toward organ preservation for esophageal cancer?

Sheraz R. Markar
, Mark van Berge Henegouwen
, Christiane Bruns
, Lorenzo Ferri
, Richard van Hillegersberg
, Wayne Hofstetter
, Magnus Nilsson^*

^*Corresponding author for this work

University of Oxford
University of Amsterdam
Amsterdam UMC
University of Cologne
McGill University
Utrecht University
University of Texas MD Anderson Cancer Center
Karolinska Institutet

Research output: Contribution to journal › Editorial › Academic › peer-review

174 Downloads (Pure)

Original language	English
Article number	doaf049
Journal	Diseases of the esophagus
Volume	38
Issue number	3
DOIs	https://doi.org/10.1093/dote/doaf049
Publication status	Published - 1 Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/dote/doaf049

Does-the-sano-trial-really-move-us-toward-organ-preservation-for-esophageal-cancer.pdfFinal published version, 235 KBLicence: Taverne

Cite this

@article{f5c2f64f6d674f04924699f24202d38e,

title = "Does the SANO trial really move us toward organ preservation for esophageal cancer?",

author = "Markar, \{Sheraz R.\} and \{van Berge Henegouwen\}, Mark and Christiane Bruns and Lorenzo Ferri and \{van Hillegersberg\}, Richard and Wayne Hofstetter and Magnus Nilsson",

year = "2025",

month = jun,

day = "1",

doi = "10.1093/dote/doaf049",

language = "English",

volume = "38",

journal = "Diseases of the esophagus",

issn = "1120-8694",